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ABSTRACT
Introduction: Proper gestational diabetes mellitus (GDM) care is essential for optimal control and thus prevents ad-
verse perinatal outcomes. This audit aimed to determine the quality of GDM care provided by a public polyclinic. 
Methods: The audit was performed on the clinic-based medical record of GDM patients who had undergone at least 
three prenatal follow-ups and one postnatal follow-up between January and November 2012. Patients with pre-exist-
ing diabetes mellitus were excluded. Results: A total of 74 medical records were audited and it showed that 94.6% 
of patients were of age 25 and above, 91.9% were Malays, 71.6% were multigravida and 98.6% had risk factors of 
GDM. 54.1% of diagnoses were made during the second trimester, while 25.7% and 20.2% of cases were detected 
during the first and third trimester respectively. All of the GDM patients had their weight and blood pressure moni-
tored, 85.1% had their fundal height checked as scheduled and 85.1% were referred for diet counselling. 81.9% and 
100% of GDM patients who were not on treatment and on treatment correspondingly had their blood sugar profile 
monitoring done as recommended. Only 13.5% of GDM patients were given prenatal family planning counselling 
and 35.1% were given a six weeks’ postnatal oral glucose tolerance test appointment. Monthly ultrasound screening 
and HbA1c monitoring was done in merely 51.4% and 58.1% of the GDM patients respectively. Conclusion: The 
GDM care process in this public polyclinic could be improved further to achieve the standard recommendations.
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INTRODUCTION
Gestational diabetes mellitus (GDM) is a hyperglycaemic 
condition with first onset or recognition during 
pregnancy and is most often diagnosed through prenatal 
screening (1). GDM affects between 2% and 7% of 
pregnant women of all pregnancies worldwide and its 
prevalence varies between different population and 
studies (2, 3). In Malaysia, the prevalence of GDM was 
18.3%  and 11.4%   in a public health clinic (4)7 and 
in a university-affiliated hospital (5) respectively. This 
rate is still significantly higher than that in most western 
populations.  
The main purpose of identifying GDM is to detect 
pregnant women at risk of adverse perinatal outcomes 
(6) .Untreated GDM not only had resulted in increased 
perinatal mortality rate up to fourfold compared with 
that of controlled GDM but it also resulted in perinatal 
morbidity. These include macrosomia, primary 
caesarean delivery, clinical neonatal hypoglycaemia, 
hyperinsulinemia, preterm birth, shoulder dystocia 
and/or birth injury, sum of skinfold thickness of above 
the 90th centile, per cent body fat of more than 
90th centile, admission for neonatal intensive care, 
hyperbilirubinaemia and preeclampsia (7). GDM 
women who are intensively treated during pregnancy 
actually had reduced risk of macrosomia, neonatal 
hypoglycaemia with glucose infusion, birth trauma, 
neonatal intensive care and shoulder dystocia while 
risks of complications such as pre-eclampia and 
caesarean section were inconsistent (8). Additionally, 
intensified  treatment of GDM reduces serious perinatal 
morbidity and may also improve the woman’s health-
related quality of life (9) .  Apart from that, women who 
are diagnosed with GDM are at high risk of developing 
diabetes mellitus (DM) later in life whereby about 10% 
of them have DM soon after delivery and the rest appear 
to develop DM at rates of 20–60% within 5–10 years 
after the index pregnancy in the absence of specific 
interventions to reduce their risk of DM (10). Therefore 
it is prudent that GDM is timely diagnosed followed by 
an appropriate treatment and monitoring. 
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Based on the Malaysian Clinical Practice Guidelines 
on Management of Type 2 Diabetes Mellitus 4th 
edition (CPG-2009) (11), ideal glucose levels should 
be achieved and maintained and  via a 4-6 weekly 
HbA1c monitoring(11). The incidence of pre-eclampsia, 
shoulder dystocia and macrosomia are greatly reduced 
with treatment consisting of diet modification, insulin 
and glucose monitoring (12). Women with GDM 
should have OGTT test performed 6 weeks after 
delivery to detect diabetes and pre-diabetes (13).  In 
patient with GDM, this standard of care is important for 
achievement of glycaemic control and hence minimizes 
both maternal and foetal complications of diabetes 
(14). Additional components in the process of care 
for DM in pregnancy apart from the above mentioned 
includes foetal surveillance, pre-eclampsia prophylaxis 
in pregnant women with pre-existing diabetes and 
decision on timing and mode of delivery (15). Foetal 
surveillance using ultrasound scan should be performed 
monthly from 28 to 36 weeks of gestation. Ultrasound-
guided management reduces the risk of large and 
small for gestational age, and macrosomic babies (16). 
According to National Institute for Health and Care 
Excellence (NICE), GDM patients with maternal or foetal 
complications should deliver by 40 weeks and 6 days 
gestation (17). Mode of delivery should be individualised, 
taking into consideration the estimated foetal weight and 
obstetric factors. However with the publication of newer 
guidelines ie Management of Diabetes in Pregnancy 
2017, HbA1c is no longer necessary for the monitoring 
of the glucose control, as there is no evidence on the 
effectiveness of HbA1c monitoring in predicting adverse 
outcomes in pregnancy.  As for the timing of delivery in 
women with gestational diabetes mellitus (GDM), those 
with no complications and good glycaemic control on 
diet alone, delivery should be planned before 40+0 
weeks, for those requiring oral antidiabetic agents or 
insulin, delivery should be planned between 37+0 and 
38+6 weeks and for those who develop maternal or 
fetal complications, elective delivery before 37+0 weeks 
should be considered (13).
As defined by NICE, “A clinical audit is a quality 
improvement procedure that aims to enhance the patient 
care and outcomes through systematic review of care 
against explicit criteria and the application of change”. It 
allows the evaluation of either the structure, the process 
or the outcome of care against a standard practice 
endorsed by clinical guidelines (18). Furthermore, the 
findings of the audit can be used to improve the health 
care delivery by implementing changes and monitoring 
outcome to confirm improvement when indicated (19). 
In view of this, this partial clinical audit was undertaken 
to determine the quality of GDM care process at one of 
the public health clinics. 
A clinical audit is justified as it is a useful tool that permits 
evaluation of the quality of care for patients with GDM 
of this clinic. This current audit was planned following a 
pilot audit of 20 GDM records by the Family Medicine 
Specialist (FMS). The unpublished internal audit yielded 
majority unachieved results despite implementing a 
lower target of performance. In view of limited local 
literature on audit of GDM care in primary care setting, 
the FMS had invited us to execute an external audit to 
provide insights towards the clinic’ performance and 
later may aid the clinic in drawing and implementing 
certain measures to overcome the deficiencies.
 
MATERIALS AND METHODS
This was a retrospective partial clinical audit conducted 
in January 2013 which involved the first three stages of 
a clinical audit, without making improvement (fourth 
stage) and re-audit to sustain improvement (fifth stage). 
The purpose of auditing the patients’ medical records 
was to evaluate the quality of GDM care provided by a 
rural public polyclinic in Selangor between January 2012 
and November 2012. It has a basic in-house laboratory, 
an X-ray unit, an out-patient clinic unit, a Maternal 
and Child Health Clinic (MCHC), an accident and 
emergency unit, a reproductive health unit, methadone 
maintenance therapy unit, quit smoking care, a dental 
clinic and school health clinic. 
The MCHC provided care to the prenatal and postnatal 
women, children below 6 years old and other related 
services such as PAP smear, family planning and 
childhood vaccination. The FMS oversaw patients in all 
units including the MCHC, while two medical officers 
(MOs) were based in MCHC for a certain period of 
time on rotation basis. The FMS provided consultation 
to cases referred by the MOs while the MOs attended 
to all cases referred by the nurses. The staff who 
manned the MCHC unit included a Matron and a Sister 
who supervised the process of care of patients and 
administration of the clinic. The nine community nurses 
took charge in terms of carrying out the process of care 
for the patients including documentation. This MCHC 
implemented traditional hardcopy record and filing 
system whereby patients kept their brief home-based 
medical record (HBMR) while the patients’ clinic-based 
medical record (CBMR) were filed in the MCHC. Both 
HBMR and CBMR were updated by the staff.
Regarding the standard process of care of GDM, this 
MCHC neither had a dedicated team nor designated 
days for GDM follow ups. All GDM patients were 
seen by the MO and if indicated, were referred to the 
FMS for further care. Appointments for monthly scans 
and fortnightly blood sugar monitoring were given by 
the MOs during their reviews. The family planning 
counselling were done opportunistically, either at any 
time during ante natal or post-partum, though most 
counselling and OGTT appointment date were given at 
one month post-partum visit. Venous blood sugar profile 
(BSP) is done four times a day at the clinic with a two 
weekly blood monitoring for all GDM patients on insulin 
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following diagnosis. Meanwhile, GDM patients who are 
not on treatment need a monthly and two weekly BSP 
for a  POG of  below 28 weeks and 28 weeks and above, 
correspondingly. 
After a thorough discussion with team members, 
considering resource limitations for the laboratory 
investigations and reviewing the literatures, we have 
decided to assess these important indicators in this 
audit with individual target level of performances such 
as referral to nutritionist/dietitian (80%), HbA1c (50%), 
prenatal family counselling (80%) and postnatal OGTT 
appointment (70%). The target levels of performance 
for weight, blood pressure and uterine fundal height 
measurement, prenatal family planning counselling, 
ultrasound screening, HbA1c test and postnatal OGTT 
appointment date were set at 100%.
 
The demographic characteristic of the patients consist of 
the age group and race while the clinical characteristics 
include the patients’ pregnancy status, period of 
gestation (POG) and risk factors for GDM. The risk 
factors, as documented on the front page of the patients’ 
CBMR (Table I) comprise a body index mass of more 
than 27kg/m2, previous macrosomic baby weighing 4 
kg or above, previous GDM, first-degree relative with 
diabetes, bad obstetric history (such as unexplained 
intrauterine death, congenital anomalies and shoulder 
dystocia), glycosuria at the first prenatal visit, current 
obstetric problems for example essential hypertension, 
pregnancy induced hypertension, polyhydramnios and 
current use of steroids as well as age above 25 years 
old. These risks are according to the CPG-2009 (11) and 
standards of medical care in diabetes by the American 
Diabetes Association (20).
All researchers were involved in the data collection. 
The standardization of data collection  was preserved as 
training session was given prior to data collection and 
the information was collected by two persons at one 
time for countercheck purpose. On top of that, data was 
checked for errors following the data entry. The CBMR of 
the patients diagnosed with GDM who had at least three 
antenatal follow-ups and one postnatal follow-up at any 
time postpartum between January 2012 and November 
2012 were chosen. Patients with pre-existing type 1 and 
type 2 DM were excluded. A total of 74 patients’ CBMR 
were selected using the universal sampling method 
from the dedicated medical records filing cabinet of 
GDM patients in the MCHC unit. Each of the CBMR 
was screened for the inclusion and exclusion criteria 
before recording the data into a structured case record 
forms. All the indicators of the GDM care process were 
recorded as ‘done’ or ‘not done’. The data obtained was 
analysed using Microsoft Excel 2007. For each indicator, 
the actual level of performance achieved was calculated 
and compared with the target level of performance. The 
summary of the processes are summarized in Table II.
Table I: Demographic and clinical characteristics of 74 patients in-
cluded in the audit 
Characteristics Frequency Percentage (%)
Age groups (years) 
More and equal to 25
Less than 25
70
4
94.6
5.4
Race
Malay
Chinese
Indian
Others
68
0
4
2
91.9
0
5.4
2.7
Gravida
Primigravida 
Multigravida
21
53
28.4
71.6
Period of Gestation (POG) at 
diagnosis
First trimester
Second trimester
Third trimester
19
40
15
25.7
54.1
20.2
Risk Factors
With  Risk Factors
Without Risk Factors
73
1
98.6
1.4
Table II: Percentage of the completed process of care as compared to 
the target level of performance 
No. Indicators of 
process
Criteria of 
indicators
Results
(percentage)
Target level 
of perfor-
mance
1. Blood Sugar 
Profile (BSP) 
Monitoring 
Patients not on 
treatment (n= 
72) 
< 28 weeks  
POG= done 
monthly 
 ≥ 28 weeks 
POG = done 
every 2 weekly 
59 
(81.9%) *
100%
Patients on 
Treatment (n=2)
- done 2 weekly 
after diagnosis
2
(100%)
100%
2. Referral to 
nutritionist / 
dietician
Done at least 
once
63
(85.1%)
80%
3. Weight Done at every 
follow up 
74 
(100%)
100%
4. Blood Pres-
sure
Done at every 
follow-up
74
(100%)
100%
5. Uterine fun-
dal height 
Done at every 
follow-up
63
(85.1%)*
100%
6. Prenatal 
Family 
Planning 
Counselling  
Done at any 
time prior to 
delivery
10
(13.5%)*
80%
7. Ultrasound 
screening
Done monthly 
since concep-
tion 
38
(51.4%)*
100%
8. Hb
A1c
Done monthly 
after diagnosis 
43
(58.1%)
50%
9. Postnatal 
OGTT ap-
pointment
Given at  6 
weeks post-de-
livery 
26
(35.1%)*
70%
*Not achieving target level of performance
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In order to explain the findings of this audit, we referred 
to both the standard process of care being practiced by 
the clinic and the CPG-2009 (11), relevant during the 
time of this clinical audit in 2012. In addition, we also 
looked at similar literatures, such as previous audits on 
GDM care at public clinics and we interviewed the staff 
of the MCHC.
RESULTS
Out of the 74 patients with GDM, 94.6% of patients 
were of age 25 and above. Majority of them (91.9%) 
were Malay and 71.6% were multigravida (Table I).  As 
for the POG at the time of GDM diagnosis, 25.7% were 
diagnosed during the first trimester while 54.1% and 
20.2% were confirmed during the second trimester and 
third trimester respectively. 98.6% (n=73) of them have 
risk factors for GDM. 
All GDM patients who were on insulin treatment had 
their suggested 2 weekly blood sugar profile (BSP) 
carried out following diagnosis.  Nevertheless, only 
81.9% of GDM patients who were not on insulin 
treatment had their BSP done as recommended. In view 
of referrals to other services, 85.1% of GDM patients 
were referred at least once to either a nutritionist or 
dietician for diet counselling. On the other hand, only 
13.5% of them were given at least once prenatal family 
planning counselling. Blood pressure and weight were 
monitored for all (100%) GDM patients but only 85.1% 
of them had their fundal height examined at each follow-
up. Monthly ultrasound and HbA1c screening were 
performed for 51.4% and 58.1% of the GDM patients 
correspondingly. Only 35.1% of patients were given a 
6-weeks post-natal oral glucose tolerance test (OGTT) 
appointment (Table II).
DISCUSSION
Most of the GDM patients in this partial clinical audit 
were multigravida (71.6%). This finding is fairly similar 
to the finding in previous studies conducted in Asia, 
such as the GDM women with multigravida were 
ranging from 63.1% - 87.6% (21, 22). Majority of the 
audited patients have underlying risk factors for GDM. 
This is not surprising as pregnant women with positive 
risk factors do have a high tendency to develop GDM 
(23). Increased risk factors for GDM were reported with 
higher maternal age, body weight and BMI, previous 
history of GDM, macrosomia and family history of 
diabetes (24, 25)
In this audit, 100% of GDM patients who were on 
insulin treatment (n = 2) had their recommended BSP 
done following diagnosis, hence achieving the target. 
Conversely, the target level of performance was not 
achieved for GDM patients who were not on insulin 
treatment. 
The blood glucose targets for both GDM patients who 
were not on insulin treatment and those who were on 
insulin treatment are as follows: fasting or pre-prandial: 
≤5.3 mmol/L, 1-hour post-prandial: ≤7.8 mmol/L, 2-hour 
post-prandial: ≤6.7 mmol/L. (13).  Insulin should be 
initiated if the targets are not achieved despite counseling 
on correct timing of BSP monitoring and adequate diet 
control.  Verbal comments by the nurses on the reasons 
for the unachieved level of performance for this indicator 
were due to the lack of consistent documentation of 
the BSP in CBMR. This is because at most times, the 
HBMR is readily available with the patients when BSP 
are reviewed, especially after working hours. Besides, 
based on the home addresses stated in the CBMR, some 
patients’ homes were far from the clinic. This distance 
issue which was further confirmed by the nurses have 
some influences on the patients’ frequent attendance 
for BSP. On the other hand, the target performance for 
prenatal referral to a weekly visiting dietician/nutritionist 
was achieved. For this clinic, group diet counseling can 
be structured by the weekly visiting dietician/nutritionist. 
This finding is also seen in a similar audit of another 
public clinic whereby dietician/nutritionist referral was 
done for 76.3% of GDM mothers despite  not having a n 
in-house dietician/nutritionist (26).
Weight and blood pressure checking had reached its 
target level of performance as nurses usually perform 
triaging prior to consultation by the doctor, at the triage 
counter for all patients regardless of their appointment 
date. Nevertheless, fundal heights were measured by 
the doctor in the consultation room only for the patients 
with a scheduled visit, rather than to all patients. This 
was a probable reason why only 85.1% of GDM patients 
had the fundal height measured, hence not achieving 
the target level of performance. A study of 2941 women 
reported SFH to be less predictive with a sensitivity of 
27% and specificity of 88% (LR+ 2.22, 95% CI 1.77–
2.78; LR– 0.83, 95% CI 0.77–0.90).(27) Factors such 
as maternal obesity, abnormal foetal lie, large fibroids, 
hydramnios and foetal head engagement result in the 
limited predictive accuracy of SFH measurement. 
Moreover, SFH has significant intra– and inter–observer 
variation  (28,29) and serial measurement may improve 
predictive accuracy (30). 
Despite achieving the target performance for monthly 
HbA1c monitoring of 50%, adequate budgeting for 
HbA1c reagents should be made available to ensure 
continuity of monitoring. The result was not unforeseen 
of a government polyclinic which has an established 
in-house medical laboratory managed by a medical 
laboratory technician without much budget constraint. 
HbA1c test reflects average plasma glucose level during 
past 3 months. However, it does not reflect accurate 
glycaemic control during pregnancy as it is influenced 
by the life span of red blood cells and iron demand. 
Besides, HbA1c is significantly higher in women with 
iron deficiency anaemia. Increasing demand of iron 
during the second and third trimester contributed to a 
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Nevertheless, since we did not complete the audit cycle 
due to time and resources constraint, we were not 
involved with any brainstorming sessions to improve the 
quality of care.
RECOMMENDATION
 
In order to improve the level of performance of GDM 
care in this clinic, the following recommendations 
which are based on the shortfalls noted during this audit 
and the clinic’ available resources are suggested. A few 
shortfalls due to failure of documentation in patients’ 
CBMR include BSP among GDM patients who were 
not on insulin treatment, the provision of a 6 weeks 
postnatal OGTT appointment, monthly ultrasound 
screening, prenatal family planning counselling and 
fundal heights measurement by the doctors. Further, the 
absence of a formal process to ensure timely postnatal 
OGTT demands a proper system to be in place.  To 
overcome the documentation issue, we recommend an 
electronic medical record system instead of the current 
traditional hardcopy medical record. This electronic 
health record system has actually been implemented 
and replaced the traditional manual record system in the 
outpatient, emergency and laboratory units of this public 
polyclinic. It is primarily clinical in focus, designed 
to provide patient details and health care provider 
decision, standard process of care and next appointment 
dates. An electronic checklist and reminders on GDM 
care processes can be installed as well. All these data 
can be backed-up to prevent any loss of data, retrieved 
conveniently, accessible to the allocated staff at any 
time and able to detect missed processes or defaulters. 
If an electronic medical record system is not feasible due 
to cost, a manual general clinic-based record book (GDM 
registry) with a manual checklist of standard GDM care 
processes can be created. This GDM registry is mainly 
used for the recordings of the names of all patients who 
visited the MCHC unit and provide accurate, complete, 
valid and reliable GDM entries, in order to determine 
the actual numbers of GDM patients who attended the 
clinic. The manual checklist on the other hand,  must 
be made available on the front pages of both patients’ 
CBMR and HBMR as it displays in-depth sections 
such as GDM screening, diagnosis, treatment, dietary 
restriction and physical exercise (35). Completed, these 
checklist shall be ticked manually by the health care 
staff as an acknowledgment that it has been executed 
(36). This front page checklist should be scrutinized by 
the nurses prior to consultation and audited regularly 
by the Sister. Any missed processes can be identified, 
rectified promptly and have been shown to reduce harm 
in some health care department (37).  
Another shortfall noted was the BSP of GDM patients 
who were not on insulin treatment. Education on the 
importance of BSP monitoring ought to be delivered to 
all GDM patients to safeguard their understanding as 
much higher level of HbA1c (31). However study also 
reported that HbA1c level in late pregnancy of GDM 
mothers is a good predictor for hypoglycaemia in the 
new born (32). Nevertheless HbA1C were performed in 
this public polyclinic as it was used as a strategy to select 
high-risk women for lifestyle interventions to prevent 
diabetes (33). In addition, measurement of HbA1c 
level for known diabetic women during pre-conception 
period is recommended to achieve good glycaemic 
control, with value aimed at less than 6.5% (11, 34)
Another less desirable performance noted was the 
provision of a 6 weeks postnatal OGTT appointment 
with only 35.1% of GDM patients were given this 
important appointment date. Postnatal follow-up 
with OGTT is crucial as some of these patients may 
manifest impaired glucose tolerance (IGT) or diabetes 
mellitus. If the postnatal evaluation is normal, patients 
should be instructed on the symptoms of diabetes and 
have an annual evaluation of glucose metabolism by a 
fasting plasma glucose level. According to the staff, the 
postnatal OGTT appointment date was not documented 
in the patients’ CBMR but was instead documented in 
their HBMR. Likewise, monthly ultrasound screening 
did not reach its target although it should be done 
monthly to detect foetal growth and complications such 
as macrosomia and polyhydramnios. However, there 
were only 51.4% (n = 38) of mothers with GDM here 
who have had their monthly ultrasound scans done. As 
revealed by the staff, ultrasound screening may have 
been done in the private clinics and were documented 
only in the patients’ HBMR which were readily available 
at the times the scans were done, but were then not 
redocumented in their CBMR during subsequent 
consultations with the doctors. Further, there was only 
one unit of ultrasound machine in this MCHC during 
the clinical audit. This may contribute to the low 
performance of this indicator in this audit.
The worst performance was prenatal family planning 
counselling whereby only 13.5% of GDM patients were 
given at least once prenatal family planning counselling. 
The reason for this as stated by the staff was the doctors 
who saw the referred GDM patients claimed that they 
had provided verbal personal counselling without proper 
documentation due to higher numbers of patients as 
compared to available doctors. There were only one FMS 
who were based in the outpatient unit most of the time, 
and two rotational MOs attending to all referred cases 
of mothers and children in MCHC. During the clinical 
audit, the daily numbers of referred cases reached up to 
100 cases that each doctor attended to about 30 patients 
each day. Other MCHC patients who were not referred 
to the doctors for prenatal and postnatal care received 
routine documented group prenatal family planning 
counselling from the nurses. 
The findings of this clinical audit were presented to 
the FMS via a formal hard copy report and discussion. 
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education was shown to improve patient’s knowledge 
and awareness on their health status, and increase 
their seriousness toward recovery, therefore enhancing 
their attendance as scheduled (23). For patients who 
face barriers in attending the four times a day BSP 
appointment at the clinic, a home-based BSP done by 
the patients or their family using a glucometer loaned 
by the clinic can be substituted. Another alternative is 
delegating the BSP to the staff at the rural clinics which 
is nearest to the patients’ residency. We also suggest 
a short-messaging-system (SMS) to remind patients at 
least one day prior to the BSP schedule. Besides that, 
we also propose a defaulter tracing program at the end 
of each clinic day to trace patients who failed to attend 
the BSP. These are worth trying, as trials using mobile 
technology-based intervention to improve health care 
delivery services showed modest benefits. 
The worst underperformance noted in this clinical 
audit was the prenatal family planning counselling. 
Traditionally, patients with GDM were counselled 
by the doctors personally during consultation while 
other patients who were not referred to the doctors 
were counselled in groups by the nurses. Improper 
documentation by the doctors can be addressed by 
the manual or electronic checklist and medical record 
system. Whereas to safeguard that the counselling 
is delivered timely, all patients with GDM can be 
enrolled into the existing group prenatal family planning 
counselling for other patients which is provided by 
the nurses or doctors at monthly interval. It induces 
understanding and motivation among the patients to 
adopt a healthy lifestyle such as weight loss and exercise 
that can reduce GDM risk and overall diabetic morbidity 
while improving glycaemic control (36). Intensified 
counselling during antenatal visit was shown to improve 
the postnatal complications (259). Further, all patients 
should receive contraceptive advice and counselling 
regarding future pregnancies (36) as they were proven to 
be effective to reduce the risk of diabetes among women 
with previous GDM (38).
To strengthen their knowledge, cooperation and 
responsibility sharing of the healthcare providers, a 
continuous medical education on the best practice 
of GDM care should be made available (39). Nurses 
should check whether the standard process had been 
done and perform the routine examination at every visit 
before sending the GDM patients to the doctor. All these 
changes however need monitoring by the superior staff 
to ensure sustainability. Finally, to complete the cycle 
of a clinical audit, changes of practice based on the 
above mentioned recommendations followed by further 
monitoring should be in place to confirm improvement 
in the healthcare delivery.  
LIMITATIONS
The absence of a proper GDM registry during the audit 
limits this retrospective partial clinical audit. There was 
a possibility of missing data, illegible or incomplete 
documentation and unknown actual number of GDM 
patients. In addition, the filing of records was not 
systematic enough which had led to difficulty in tracing 
the data, laboratory results as well as the laboratory 
orders forms. Furthermore, the audit findings are limited 
by the issue of discordance between the home-based 
and clinic-based records.  Finally this clinical audit is 
a part of the complete clinical audit cycle, without the 
application and monitoring of change and its’ outcome 
on healthcare. Hence, it is hoped that a complete cycle 
can be conducted in near future to enhance its usability.
CONCLUSION
In conclusion, there is a gap between guidelines and 
clinical practice in the provision of GDM care as shown 
by this audit. The quality of care in carrying out BSP 
among GDM mothers not on insulin, adherence of 
ultrasound service, counselling of family planning and 
appointment for post-partum OGTT were found to be 
suboptimal hence needing certain measures to improve 
it. With combination of the patients and healthcare 
providers’ education, upgrading the systems involved 
and frequent clinical audit could improve the quality of 
GDM care in this public polyclinic. This clinical audit 
contributes towards the literature on the management of 
GDM in primary care and may serve as a baseline data 
which can guide future clinical audit.
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